Replies to post #430448 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

Specifically imo a 25% chance of AA.

Strong surrogate biomarker(s) is what AA is made of when they reasonably indicate likely clinical benefits. That Anavex are giving us 1 coprimary and 1 secondary endpoint that do point to meaningful clinical benefits is helpful and likely stronger than those in recent AD approvals is all the better.

[WolfofMia]

I mean the only reason, I'm in the wgt group is because his 25%.

He made me join with his optimism!

Now I just need Docs approval.